Australian Clinical Labs falls to over two-week low on trading ex-dividend
BUZZ-Australian Clinical Labs falls to over two-week low on trading ex-dividend ** Shares of Australian Clinical Labs ACL.AX falls as much as 6.1% to A$2.630, hitting its lowest since August 17
** Stock last down 2.9%, on track for its weakest session since August 26 if gains hold
** The pathology services provider had announced final dividend of A$0.09250 on August 17
** YTD, stock down 1.1% including moves in current session
(Reporting by Tejas Harish in Bengaluru)
Recent news on Australian Clinical Labs
See all newsBrief: Australian Clinical Labs Appoints Deloitte As Auditor
Australia's Optiscan rises after imaging more than 80 cases in ACL study
Australian Clinical Labs falls to over two-week low on trading ex-dividend
Australian Clinical Labs at 6-month high on upbeat full-year results, guidance
Brief: Australian Clinical Labs Says It Expects FY27 Revenue Of A$745-765 Million